Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease—The McGill experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease—The McGill experience

Published:2014-11 Issue:11 Volume:8 Page:1516-1522
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

Kopylov U.,Afif W.,Cohen A.,Bitton A.,Wild G.,Bessissow T.,Wyse J.,Al-Taweel T.,Szilagyi A.,Seidman E.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/8/11/1516/1024538/8-11-1516.pdf

Reference16 articles.

1. The future of inflammatory bowel disease therapy: where do we go from here?;Sandborn;Dig. Dis.,2012

2. Assessing response and loss of response to biological therapies in IBD;Yanai;Am. J. Gastroenterol.,2011

3. Ustekinumab induction and maintenance therapy in refractory Crohn's disease;Sandborn;N. Engl. J. Med.,2012

4. Review of the safety and efficacy of ustekinumab;Scherl;Ther. Adv. Gastroenterol.,2010

5. Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases;Strober;Gastroenterology,2011

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU;Digestive and Liver Disease;2024-06

2. Clinical effectiveness and safety of ustekinumab in youth with refractory inflammatory bowel disease: A retrospective cohort study;Saudi Journal of Gastroenterology;2024-04-10

3. Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn’s Disease;Journal of Clinical Medicine;2024-03-07

4. Disseminated Mycobacterial Infection With Reactive Polyarthritis (Poncet’s Disease) During Immune-suppressive Treatment Including Ustekinumab for Pediatric Crohn’s Disease;Pediatric Infectious Disease Journal;2024-02-20

5. Real-world effectiveness and safety of ustekinumab in bio-naive patients with moderate-to-severe Crohn's disease: A Canadian multi-center study;Digestive and Liver Disease;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3